Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biliary Tract Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07186842
What this trial is testing

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

Who this might be right for
Advanced Solid Cancers
BioNTech SE 245
Testing effectiveness (Phase 2)Ended earlyNCT00012246
What this trial is testing

Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract

Who this might be right for
Colorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+4 more
The University of Texas Medical Branch, Galveston 7
Not applicableLooking for participantsNCT07161869
What this trial is testing

Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III)

Who this might be right for
Hilar CholangiocarcinomaIntrahepatic Cholangiocarcinoma (Icc)Cholangiocarcinoma+3 more
Erasmus Medical Center 250
Not applicableUnknownNCT04584996
What this trial is testing

CIRcular and Non-coding RNAs as Clinically USeful Biomarkers in Pancreaticobiliary Cancers

Who this might be right for
Pancreatic CancerBiliary Tract Cancer
Royal Surrey County Hospital NHS Foundation Trust 186
Early research (Phase 1)UnknownNCT04608786
What this trial is testing

A Clinical Study of PD-L1 Antibody ZKAB001 Combined With Capecitabine in Resected Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Lee's Pharmaceutical Limited 10
Testing effectiveness (Phase 2)Looking for participantsNCT05784688
What this trial is testing

Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorBiliary Tract CancerHead and Neck Squamous Cell Carcinoma+1 more
TiumBio Co., Ltd. 140
Testing effectiveness (Phase 2)Study completedNCT04656249
What this trial is testing

Lenvatinib in Patients With Previously Treated Advanced Biliary Tract Cancer

Who this might be right for
CholangiocarcinomaBiliary Tract CancerTargeted Therapy
Peking Union Medical College Hospital 46
Not applicableEnrolling By InvitationNCT06076252
What this trial is testing

Modified vs Conventional Blumgart Anastomosis of LPD for the Effects of Pancreatic Fistula of Periampullary Carcinoma

Who this might be right for
Ampullary CancerBile Duct CancerPancreas Cancer+1 more
Affiliated Hospital of Guangdong Medical University 150
Not applicableLooking for participantsNCT07007832
What this trial is testing

Bile Omics for Diagnosing Indeterminate Biliary Strictures

Who this might be right for
CholangiocarcinomaGallbladder Cancer and Extrahepatic CholangiocarcinomaPancreatic Cancer+2 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 260
Testing effectiveness (Phase 2)Study completedNCT02346032
What this trial is testing

Phase II Study of Refametinib, a MEK Inhibitor, as Second-line Treatment in Advanced Biliary Tract Adenocarcinoma

Who this might be right for
Biliary Tract Cancer
Samsung Medical Center 4
Testing effectiveness (Phase 2)Study completedNCT04072445
What this trial is testing

Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer

Who this might be right for
Advanced Bile Duct CarcinomaAdvanced Gallbladder CarcinomaRefractory Bile Duct Carcinoma+15 more
Mayo Clinic 28
Large-scale testing (Phase 3)Study completedNCT00513539
What this trial is testing

Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder Cancer
University College, London 92
Testing effectiveness (Phase 2)Study completedNCT00634751
What this trial is testing

CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma

Who this might be right for
Pancreatic NeoplasmsBile Duct Neoplasms
University of Wisconsin, Madison 48
Testing effectiveness (Phase 2)Study completedNCT00059865
What this trial is testing

Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Alliance for Clinical Trials in Oncology 68
Large-scale testing (Phase 3)Study completedNCT00363584
What this trial is testing

Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
University Hospital Southampton NHS Foundation Trust 360
Testing effectiveness (Phase 2)Looking for participantsNCT07135544
What this trial is testing

A Single-arm, Multicenter, Exploratory Study of Adebrelimab Combined With Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerBiliary Tract Cancer (CCA)
Yongjun Chen 37
Testing effectiveness (Phase 2)Looking for participantsNCT05757336
What this trial is testing

Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer

Who this might be right for
Gallbladder CancerInitially Unresectablethe First Line Treatment
Lu Wang, MD, PhD 50
Not applicableStudy completedNCT04572711
What this trial is testing

Prospective Evaluation of Biliary Tissue Sampling With ERCP

Who this might be right for
Cholangiopancreatography, Endoscopic RetrogradeBiliary StrictureBiliary Tract Diseases+1 more
Mayo Clinic 327
Early research (Phase 1)Ended earlyNCT02267707
What this trial is testing

Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia

Who this might be right for
Pancreatic NeoplasmsCholestasis
Celgene 1
Early research (Phase 1)Not Yet RecruitingNCT06490198
What this trial is testing

Phase 2 Study: OBI-833/OBI-821 Maintenance for Globo H+ Advanced Biliary Tract Cancer After Gemcitabine/Cisplatin

Who this might be right for
CholangiocarcinomaChemotherapy EffectImmunotherapy
Chang Gung Memorial Hospital 30
Next Page